Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.
about
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia.Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents.
P2860
Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Costs and outcomes of treating ...... nationwide multicenter trial.
@en
type
label
Costs and outcomes of treating ...... nationwide multicenter trial.
@en
prefLabel
Costs and outcomes of treating ...... nationwide multicenter trial.
@en
P2093
P2860
P356
P1476
Costs and outcomes of treating ...... nationwide multicenter trial.
@en
P2093
H Pfeiffer-Vornkahl
J T Stahmeyer
P2860
P304
P356
10.1111/JVH.12471
P577
2015-09-28T00:00:00Z